Regencell Bioscience Holdings Limited (NASDAQ:RGC – Get Free Report) shares dropped 18.8% during trading on Wednesday . The stock traded as low as $53.01 and last traded at $63.35. Approximately 1,720,851 shares traded hands during mid-day trading, an increase of 22% from the average daily volume of 1,411,872 shares. The stock had previously closed at $78.00.
Regencell Bioscience Stock Performance
About Regencell Bioscience
Regencell Bioscience Holdings Limited operates a Traditional Chinese medicine (TCM) bioscience company. It focuses on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degeneration, primarily attention deficit hyperactivity disorder and autism spectrum disorder.
Recommended Stories
- Five stocks we like better than Regencell Bioscience
- Health Care Stocks Explained: Why You Might Want to Invest
- Chime’s Smart IPO: Half the Valuation, Double the Strength
- Short Selling – The Pros and Cons
- Why Quantum Computing Inc. Is the Quiet Winner in Quantum Stocks
- What is the Dow Jones Industrial Average (DJIA)?
- 3 Catalysts in 7 Days: Archer’s Growth Story Just Accelerated
Receive News & Ratings for Regencell Bioscience Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Regencell Bioscience and related companies with MarketBeat.com's FREE daily email newsletter.
